Cargando…
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Cancer immunotherapy has veered the paradigm of cancer treatment. Despite recent advances in immunotherapy for improved antitumor efficacy, the complicated tumor microenvironment (TME) is highly immunosuppressive, yielding both astounding and unsatisfactory clinical successes. In this regard, clinic...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714985/ https://www.ncbi.nlm.nih.gov/pubmed/33304779 http://dx.doi.org/10.1016/j.apsb.2020.08.010 |